Large-scale testing (Phase 3)Study completedNCT00223951
What this trial is testing
Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers
Who this might be right for
Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis
Vistakon Pharmaceuticals 900